TrialTargeted oncology2018

Gemcitabine Combined with the mTOR Inhibitor Temsirolimus in Patients with Locally Advanced or Metastatic Pancreatic Cancer. A Hellenic Cooperative Oncology Group Phase I/II Study.

Vasilios Karavasilis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.